当前位置:首页 - 行情中心 - 卫光生物(002880) - 财务分析

卫光生物

(002880)

  

流通市值:65.80亿  总市值:66.02亿
流通股本:2.26亿   总股本:2.27亿

卫光生物(002880)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.83亿元,每股收益0.81元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益217280.55万元,未分配利润118024.80万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产317120.79万元,负债99840.24万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入854,101,695.51522,902,745.97226,302,459.951,048,502,589.77
营业总成本639,313,587.41392,463,709.82171,996,950.01826,102,717.53
营业利润217,276,259.92131,796,653.8355,379,544.53247,308,674.6
利润总额216,653,689.69131,335,735.4855,340,653.7245,454,612.53
净利润182,526,379.42109,727,347.8346,793,784.04217,544,635.84
其他综合收益----
综合收益总额182,526,379.42109,727,347.8346,793,784.04217,544,635.84
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,439,940,355.731,383,564,452.11,259,342,072.471,103,704,876.04
非流动资产合计1,731,267,580.761,694,840,660.541,773,920,160.511,773,073,881.8
资产总计3,171,207,936.493,078,405,112.643,033,262,232.982,876,778,757.84
流动负债合计370,562,358.45366,326,742.09328,853,795.74265,989,198.92
非流动负债合计627,840,068.24612,071,892.35611,975,739.04565,150,306.32
负债合计998,402,426.69978,398,634.44940,829,534.78831,139,505.24
归属于母公司股东权益合计2,140,609,538.842,067,770,830.342,061,110,245.642,014,278,388.32
股东权益合计2,172,805,509.82,100,006,478.22,092,432,698.22,045,639,252.6
负债和股东权益合计3,171,207,936.493,078,405,112.643,033,262,232.982,876,778,757.84
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计814,550,758.1551,781,646.68227,799,769.871,228,276,307.73
经营活动现金流出小计713,571,313.26475,507,932.85239,519,155.26830,337,542.5
经营活动产生的现金流量净额100,979,444.8476,273,713.83-11,719,385.39397,938,765.23
投资活动现金流入小计131,617.9126,841.2126,841.273,394.41
投资活动现金流出小计202,871,023.87152,167,618.2646,472,075.22352,240,031.19
投资活动产生的现金流量净额-202,739,405.97-152,040,777.06-46,345,234.02-352,166,636.78
筹资活动现金流入小计243,023,091.82215,363,296.33154,378,416.9179,966,615.4
筹资活动现金流出小计136,901,049.8685,847,886.5411,447,733.56268,146,790.56
筹资活动产生的现金流量净额106,122,041.96129,515,409.79142,930,683.34-88,180,175.16
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额4,362,080.8353,748,346.5684,866,063.93-42,408,046.71
期末现金及现金等价物余额255,807,762.34305,194,028.07336,343,535.12251,444,681.51
最新报告期:2024-11-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西南证券杜向阳1.141.351.632024-11-01
中信证券陈竹1.131.301.482024-09-02
TOP↑